![](/img/cover-not-exists.png)
Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity
Robichaux, Jacqulyne P., Elamin, Yasir Y., Vijayan, R.S.K., Nilsson, Monique B., Hu, Lemei, He, Junqin, Zhang, Fahao, Pisegna, Marlese, Poteete, Alissa, Sun, Huiying, Li, Shuai, Chen, Ting, Han, Han,Volume:
37
Language:
english
Journal:
Cancer Cell
DOI:
10.1016/j.ccell.2020.03.003
Date:
March, 2020
File:
PDF, 194 KB
english, 2020